Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007, 151(1):59-64 | DOI: 10.5507/bp.2007.010

NOVEL IMMUNOHISTOCHEMICAL MARKERS FOR THE DIFFERENTIATION OF LOBULAR AND DUCTAL INVASIVE BREAST CARCINOMAS

Gulisa Turashvilia, Jan Bouchala, Jiri Ehrmanna, Eduard Fridmanb, Jozef Skardaa, Zdenek Kolara
a Laboratory of Molecular Pathology, Department of Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
b Department of Pathology, Tel Aviv University, Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv, Israel

Aims: Invasive ductal and lobular carcinomas are the most common histological types of breast cancer. The loss of E-cadherin expression has been suggested to be the most reliable marker for invasive lobular carcinoma. The aim of our study was to identify the diagnostic usefulness of novel markers in the differentiation of these tumor types.

Methods: We examined tissue microarrays (TMA) which were constructed from surgical specimens of 119 breast cancer patients. TMA consisted of 80 ductal carcinomas, 29 lobular carcinomas and special type cancers. TMA sections were stained using standard immunohistochemical methods. Monoclonal mouse antibodies against E-cadherin, cytokeratin 5/6 and 17, and polyclonal mouse antibodies against EMP1, DDR1, PRKCI and DVL1 were used.

Results: E-cadherin was absent in 93.3 % of lobular tumors compared with only 15 % of ductal tumors (p < 0.0001). EMP1 and DVL1 were overexpressed in lobular tumors (93.1 % and 96.5 %, respectively), whereas PRKCI and DDR1 were positive in ductal cancers (90 % and 96.2 %, respectively). Reduced expression or absence of both cytokeratins 5/6 and 17 was found in both tumor tissues in comparison to normal terminal duct lobular units (p < 0.0001).

Conclusions: Apart from the well-established marker, E-cadherin, proteins examined on TMA slides by immunohistochemistry (EMP1, DVL1, DDR1, PRKCI) may represent novel tissue markers helpful in the differentiation of ductal and lobular breast cancers. Further studies with larger sets of patients are desirable, to verify the complete immunohistochemical profiles of various histological types of breast cancer and determine the prognostic and predictive significance of novel markers.

Keywords: Breast cancer, Ductal carcinoma, Lobular carcinoma, Immunohistochemistry, E-cadherin, Tissue microarray

Received: March 22, 2007; Accepted: May 18, 2007; Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Turashvili, G., Bouchal, J., Ehrmann, J., Fridman, E., Skarda, J., & Kolar, Z. (2007). NOVEL IMMUNOHISTOCHEMICAL MARKERS FOR THE DIFFERENTIATION OF LOBULAR AND DUCTAL INVASIVE BREAST CARCINOMAS. Biomedical papers, 151(1), 59-64. doi: 10.5507/bp.2007.010
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infi ltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004;6:R14956. Go to original source... Go to PubMed...
    2. Asge ir sson KS. Alte red expres si on of E-cad he rin in bre ast cancer, pat terns, mec ha nisms and cli ni cal sig ni fi can ce. Eur J Can cer 2000;36:1098106. Go to original source... Go to PubMed...
    3. Daly LE, Bourke GJ. Interpretation and uses of medical statistics, 5th edn. Oxford: Blackwell Science 2000; 4125. Go to original source...
    4. De Donato M, Gallagher Jr. DS, Davis SK, Stelly DM, Taylor JF. The assignment of PRKCI to bovine chromosome 1q34-q36 by FISH suggests a new assignment to human chromosome 3. Cytogenet. Cell Genet. 2001;95:7981. Go to original source... Go to PubMed...
    5. Dej mek J, Dib K, Jon sson M, Ander sson T. Wnt-5a and G-prote in sig na ling are re qu i red for col la gen-indu ced DDR1 re cep tor acti va ti on and nor mal mam mary cell adhe si on. Int J Can cer 2003;103:34451. Go to original source...
    6. Dejmek J, Leandersson K, Manjer J, Bjartell A, Emdin SO, Vogel WF, et al. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clin Cancer Res 2005;11:5208. Go to original source...
    7. Durmus T, Leclair RJ, Park KS, Terzic A, Yoon JK, Lindner V. Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1). 2006;6:93540 Go to original source... Go to PubMed...
    8. Ferlicot S, Vincent-Salomon A, Medioni J, Genin P, Rosty C, Sigal- Zafrani B, et al. Wide metastatic spreading in infi ltrating lobular carcinoma of the breast. Eur J Cancer 2004;40:33641. Go to original source... Go to PubMed...
    9. Gel mann EP, Bo wen C, Bu ben dorf L. Expres si on of NKX3.1 in nor mal and ma lignant tissues. Prosta te 2003;55:1117. Go to original source... Go to PubMed...
    10. Goldstein NS, Bas si D, Watts JC, Lay fi eld LJ, Ya zi ji H, Gown AM. E-cad he rin re ac ti vity of 95 no nin va si ve duc tal and lo bu lar le si ons of the bre ast. Impli ca ti ons for the inter pre ta ti on of prob le ma tic le si ons. Am J Clin Pat hol 2001;115:53442. Go to original source... Go to PubMed...
    11. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee- Kwon W, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003;63:21728.
    12. Gup ta D, Cro i to ru CM, Aya la AG, Sa hin AA, Mid dle ton LP. Ecadherin immu nohistoc hemical anal ysis of histiocytoid car cinoma of the bre ast. Ann Di agn Pat hol 2002;6:1417. Go to original source... Go to PubMed...
    13. Jonsson M, Andersson T. Repression of Wnt-5a impairs DDR1 phosphorylation and modifi es adhesion and migration of mammary cells. J Cell Sci 2001;114:204353. Go to original source...
    14. Kim DH, Yoon DS, Dooley WC, Nam ES, Ryu JW, Jung KC, et al. Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer. Histopathology 2003;42:3742. Go to original source... Go to PubMed...
    15. Ko wal ski PJ, Ru bin MA, Kle er CG. E-cad he rin expres si on in primary car ci no mas of the bre ast and its dis tant me tas ta ses. Bre ast Can cer Res 2003;5:R21722. Go to original source...
    16. Mersin H, Yildirim E, Gulben K, Berberoglu U. Is invasive lobular carcinoma diff erent from invasive ductal carcinoma? Eur J Surg Oncol 2003;29:3905. Go to original source...
    17. Mil ler JR. The Wnts. Ge no me Biol 2002;3:3001.13001.15.
    18. Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. Infi ltrating lobular carcinoma a comparison of diagnosis, management and outcome with infi ltrating duct carcinoma. Breast 2004;13:38996. Go to original source... Go to PubMed...
    19. Nagahata T, Shimada T, Harada A, Nagai H, Onda M, Yokoyama S, et al. Amplifi cation, up-regulation and over-expression of DVL- 1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci 2003;94:5158. Go to original source... Go to PubMed...
    20. Na ko po u lo u L, Ga ki o po u lo u-Gi va lo u H, Ka ra yi an na kis AJ, Gi an - no po u lo u I, Ke ra mo po u los A, Da va ris P, Pig na tel li M. Abnor mal alpha-ca te nin expres si on in inva si ve bre ast can cer cor re la tes with poor pa ti ent sur vi val. His to pat ho logy 2002;40:53646.
    21. Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, et al. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 2002;9:22834. Go to original source... Go to PubMed...
    22. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004;48:365375. Go to original source... Go to PubMed...
    23. Rosen PP. Rosens breast pathology. Lippincots-Raven Publishers; 1997.
    24. Roy lan ce R, Dro u fa kou S, Gor man P, Gil lett C, Hart IR, Hanby A, Tom lin son I: The role of E-cad he rin in low-gra de duc tal bre ast tumori ge ne sis. Pat hol 2003;200:538.
    25. Sar ri o D, Pe rez-Mies B, Har dis son D, Mo re no-Bu e no G, Su a rez A, Cano A, et al. Cytop las mic lo ca li za ti on of p120ctn and E-cadhe rin loss cha rac te ri ze lo bu lar bre ast car cinoma from prein va si ve to me tasta tic lesions. Oncoge ne 2004;23:327283. Go to original source... Go to PubMed...
    26. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, Gamagami P. Infi ltrating lobular carcinoma. Is it diff erent from infi ltrating duct carcinoma? Cancer 1994;73:1673 7. Go to original source... Go to PubMed...
    27. Simon R, Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumors. Exp Hematol 2002;30:136572. Go to original source... Go to PubMed...
    28. Simpson P, Reis-Filho J, Gale T, Lakhani S. Molecular evolution of breast cancer. J Pathol 2005;205:248254. Go to original source... Go to PubMed...
    29. Smal ley M, Dale TC. Wnt sig naling and mam mary tumori ge nesis. J. Mamm. Gland Biol. Ne op la si a 2001;6:3752.
    30. Tlsty TD, Craw ford YG, Holst CR, Fordyce CA, Zhang J, McDermott K, et al. Ge ne tic and epi ge ne tic chan ges in mam mary epit helial cells may mi mic early events in car cinoge nesis. J Mamm Gland Biol Ne oplasia 2004;9:26374. Go to original source... Go to PubMed...
    31. Toikkanen S, Pylkkanen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997;76:123440. Go to original source... Go to PubMed...
    32. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, et al. Expression of cytokeratins 17 and 5 identifi es a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002;161:19916. Go to original source... Go to PubMed...
    33. Weidner N, Cote R, Suster S, Weiss L. Modern Surgical Pathology. Elsevier Science; 2003.
    34. Yamanaka H, Moriguchi T, Masuyama N, Kusakabe M, Hanafusa H, Takada R, et al. JNK functions in the noncanonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep 2002;3:6975. Go to original source... Go to PubMed...
    35. Zhao X, Ramsey KE, Stephan DA, Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci 2004;45:402334. Go to original source...

    Return to the content